Understanding how tRNA affects antisynthetase syndrome
Explore the involvement of tRNA in the pathophysiology of antisynthetase syndrome
This research looks into how small molecules called tRNAs might contribute to antisynthetase syndrome, a condition causing muscle weakness and lung problems.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scripps Research Institute, the NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11167619 on NIH RePORTER |
What this research studies
Antisynthetase syndrome (ASSD) is an autoimmune disease that causes muscle inflammation, known as myositis, and scarring in the lungs, called interstitial lung disease. Patients with ASSD often have special antibodies that target enzymes called aminoacyl-tRNA synthetases (aaRSs), which are vital for building proteins in our cells. We don't fully understand why these enzymes become targets for the immune system or how they lead to symptoms. This project suggests that tRNAs, which work closely with aaRSs, might play a key role in triggering the immune system's attack. We will use lab models and relevant cells to study this idea and develop new ways to understand and potentially treat ASSD.
Who could benefit from this research
Good fit: This foundational research is for patients with antisynthetase syndrome, especially those with myositis and interstitial lung disease, who are interested in the underlying causes of their condition.
Not a fit: Patients without antisynthetase syndrome or those seeking immediate treatment options may not directly benefit from this early-stage research.
Why it matters
Potential benefit: The results from this work could lead to new ways to understand and treat antisynthetase syndrome, potentially improving symptoms like muscle weakness and lung issues.
How similar studies have performed: While the specific role of tRNAs in antisynthetase syndrome is a novel area of focus, other studies have shown the importance of immune signaling pathways like TLR7 and IFN-I in autoimmune diseases.
Where this research is happening
La Jolla, United States
- Scripps Research Institute, the — La Jolla, United States (Active)
Researchers
- Principal investigator: Yang, Xiang-Lei — Scripps Research Institute, the
- Study coordinator: Yang, Xiang-Lei
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.